Research location
Brussels
Brussels Capital, Belgium
Advertisement
Research activity in Brussels
Brussels Capital, BelgiumCureCurrent currently publishes aggregate city-level research activity for this location: 62 trials and 77 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Brussels
62 linked trials · page 1 of 2A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic DysfunctionNCT07192952 · 2026-06-01 · 1 site observation
RECRUITING
Predicting Weight Loss After Pharmacological or Surgical Treatment in Patients With ObesityNCT07402031 · 2026-05-05 · 1 site observation
RECRUITING
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerNCT07085767 · 2025-11-03 · 1 site observation
RECRUITING
Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)NCT06150898 · 2025-05-12 · 1 site observation
RECRUITING
Study of Lipid Mediators in Chronic Postoperative Pain - LICPNCT06907810 · 2025-03-12 · 1 site observation
RECRUITING
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceNCT06492616 · 2024-09-27 · 2 site observations
RECRUITING
HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011NCT06369831 · 2024-09-12 · 4 site observations
RECRUITING
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT06236438 · 2024-04-10 · 1 site observation
RECRUITING
Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid ArthritisNCT06003283 · 2024-01-09 · 1 site observation
RECRUITING
Study of Combined GARP:TGF-β1/PD-1 Blockade as a Shock-and-kill Strategy in HIV-1 CureNCT07692932 · 2026-08-31 · 1 site observation
NOT_YET_RECRUITING
A Study of Mosliciguat in PH-ILDNCT06635850 · 2024-10-29 · 1 site observation
ACTIVE_NOT_RECRUITING
Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual TreatmentNCT06828640 · 2024-10-16 · 1 site observation
UNKNOWN
Ventilation Distribution in COPD Patients During Breathing ExercisesNCT06381973 · 2024-04-15 · 1 site observation
COMPLETED
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)NCT06018337 · 2024-01-18 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382NCT06032546 · 2023-10-12 · 2 site observations
TERMINATED
Prevalence of Glaucoma in Belgium: a Multicenter National TrialNCT05703724 · 2023-03-08 · 2 site observations
COMPLETED
Occupational and Environmental Causes of Autoimmune DiseasesNCT07000903 · 2022-05-10 · 1 site observation
COMPLETED
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)NCT05147220 · 2021-12-16 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)NCT04712669 · 2021-03-15 · 1 site observation
COMPLETED
A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid ArthritisNCT04497597 · 2020-10-16 · 1 site observation
COMPLETED
tDCS of the Primary Motor Cortex to Improve Implicit Motor Sequence Learning in Parkinson's DiseaseNCT04606979 · 2020-10-11 · 1 site observation
COMPLETED
Rheumatoid Arthritis Synovial Tissue Biopsy StudyNCT07000890 · 2020-06-23 · 1 site observation
COMPLETED
TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion MutationsNCT04129502 · 2020-01-10 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CTNCT04168528 · 2019-11-05 · 1 site observation
TERMINATED
Effects of SIMEOX on Static Hyperinflation in Patients With COPDNCT04157972 · 2019-08-05 · 1 site observation
COMPLETED
Effects of SIMEOX on Flow and Volume in Healthy Subjects and Patients With COPDNCT04150601 · 2019-08-01 · 1 site observation
COMPLETED
Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerNCT03778931 · 2019-05-10 · 4 site observations
COMPLETED
Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.NCT03476109 · 2019-05-10 · 1 site observation
UNKNOWN
Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of TeplizumabNCT03875729 · 2019-04-05 · 1 site observation
COMPLETED
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma PatientsNCT03924466 · 2019-04-01 · 1 site observation
UNKNOWN
Effects of Endoscopic Lung Volume Reduction on Diaphragm Function and ConformationNCT05799352 · 2019-04-01 · 1 site observation
COMPLETED
Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid TumorsNCT03821935 · 2019-02-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Assessment of Adherence to Controller Inhalation Medication in Asthma- and COPD Patients.NCT03791658 · 2019-01-02 · 1 site observation
COMPLETED
A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid ArthritisNCT03682705 · 2018-10-08 · 1 site observation
COMPLETED
Phase IIb Study Evaluating Immunogenic Chemotherapy Combined With Ipilimumab and Nivolumab in Breast CancerNCT03409198 · 2018-01-21 · 2 site observations
COMPLETED
Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)NCT03061812 · 2017-04-11 · 1 site observation
COMPLETED
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)NCT03033511 · 2017-02-07 · 1 site observation
TERMINATED
Long-term Outcome of GnRH Analogues Treatment of Children With Idiopathic Central Precocious PubertyNCT02790112 · 2016-04-01 · 1 site observation
UNKNOWN
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsNCT02552121 · 2015-11-30 · 1 site observation
COMPLETED
Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast CancerNCT02492711 · 2015-08-24 · 2 site observations
COMPLETED
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast CancerNCT02246621 · 2014-11-06 · 1 site observation
ACTIVE_NOT_RECRUITING
TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free RegimenNCT02053597 · 2014-10-01 · 2 site observations
WITHDRAWN
BACE Trial Substudy 1 - PROactive SubstudyNCT02205242 · 2014-09-01 · 1 site observation
COMPLETED
BACE Trial Substudy 2 - FarmEc SubstudyNCT02205255 · 2014-08-01 · 1 site observation
COMPLETED
Azithromycin for Acute Exacerbations Requiring HospitalizationNCT02135354 · 2014-08-01 · 1 site observation
TERMINATED
Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)NCT02134015 · 2014-03-01 · 1 site observation
TERMINATED
Study of the ICG Distribution in Breast Tumours or in Axillary Lymph Nodes of Patients After Neoadjuvant TherapyNCT02032563 · 2013-12-01 · 1 site observation
UNKNOWN
Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanningNCT01950871 · 2013-10-01 · 2 site observations
TERMINATED
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)NCT01942135 · 2013-09-26 · 1 site observation
COMPLETED
Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLCNCT01913067 · 2013-09-01 · 1 site observation
WITHDRAWN
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.